Stem Point Capital LP Wave Life Sciences Ltd. Transaction History
Stem Point Capital LP
- $312 Billion
- Q2 2025
A detailed history of Stem Point Capital LP transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Stem Point Capital LP holds 900,338 shares of WVE stock, worth $6.34 Million. This represents 1.88% of its overall portfolio holdings.
Number of Shares
900,338
Previous 89,833
902.24%
Holding current value
$6.34 Million
Previous $726 Million
706.25%
% of portfolio
1.88%
Previous 0.23%
Shares
4 transactions
Others Institutions Holding WVE
# of Institutions
188Shares Held
133MCall Options Held
495KPut Options Held
36.2K-
Ra Capital Management, L.P. Boston, MA18.2MShares$128 Million2.59% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA15MShares$106 Million0.17% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx8.26MShares$58.2 Million0.92% of portfolio
-
Black Rock Inc. New York, NY6.74MShares$47.4 Million0.0% of portfolio
-
Driehaus Capital Management LLC Chicago, IL6.53MShares$46 Million0.41% of portfolio
About Wave Life Sciences Ltd.
- Ticker WVE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,820,096
- Market Cap $611M
- Description
- Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...